Data as of May 21
| +0.03 / +0.10%|
Thoratec Corp. develops, manufactures and markets proprietary medical devices used for circulatory support. The company's products include the HeartMate LVAS and Thoratec VAD, with more than 20,000 devices implanted in patients suffering from heart failure. It also manufactures and markets the CentriMag and PediMag/PediVAS product lines. Its ventricular assist devices products primarily serve patients suffering from late-stage heart failure. Heart Failure is a chronic disease that occurs when degeneration of the heart muscle reduces the pumping power of the heart, causing the heart to become too weak to pump blood at a level sufficient to meet the body's demands. The company operates its business through one segment: Cardiovascular group. The Cardiovascular group is organized and operates to develop and manufacture mechanical circulatory products to support the cardiovascular systems of humans. Thoratec was founded in March 1976 and is headquartered in Pleasanton, CA.
|Gerhard F. Burbach, MBA||President, Chief Executive Officer & Director|
|Taylor C. Harris||CFO, VP & Senior Director-Investor Relations|
|David A. Lehman||Secretary, Senior Vice President & General Counsel|
|Roxanne Oulman, MBA||Vice President-Finance|